Bakhshayeshkaram Marzieh, Roozbeh Jamshid, Heidari Seyed Taghi, Honarvar Behnam, Dabbaghmanesh Mohammad Hossein, B Lankarani Kamran
Shiraz Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Int J Endocrinol Metab. 2019 Feb 27;17(2):e81822. doi: 10.5812/ijem.81822. eCollection 2019 Apr.
Chronic kidney disease (CKD) can potentially be associated with metabolic syndrome (MetS).
We aimed to determine the association of MetS and the number of metabolic syndrome components with the risk of CKD in the Iranian population in southern Iran.
A total of 819 subjects aged 18 - 88 years were enrolled using weight-based random cluster sampling. We constructed a logistic regression model to determine the adjusted odds ratios (ORs) and 95% confidence intervals (CI) of the association of MetS individual components and the number of these components with CKD.
The prevalence rate of MetS was 25.9% (30.9% in women and 18.8% in men). CKD was present in 16.6% of the participants (men: 14% and women: 19.4%). The most prevalent component was abdominal obesity (63.6%), followed by low HDL cholesterol (36.7%), high triglyceride level (31.7%), hypertension (25.6%) and high fasting blood sugar (21.9%). Central obesity and low HDL level were observed to be more prevalent among women (P < 0.001). The presence of MetS was associated with CKD with an increased OR for CKD (OR: 3.07, 95% CI 2.09 - 4.50; P < 0.001). The adjusted ORs (95% CI) were 1.189 (0.554 - 2.555), 2.025 (0.990 - 4.141) and 4.769 (2.413 - 9.424) as the number of risk factors increased from 1 to ≥ 3. Individuals with hypertension and abdominal obesity had a higher OR of increased susceptibility to CKD in multivariate analysis.
Our study indicated a strong association between CKD and MetS in the Iranian population. It is also suggested that individuals with metabolic risk factors should be detected earlier; they should also undergo multidisciplinary interventions to hinder worsening of the individual components of MetS and development of CKD.
慢性肾脏病(CKD)可能与代谢综合征(MetS)相关。
我们旨在确定伊朗南部人群中代谢综合征及其各组分数量与慢性肾脏病风险之间的关联。
采用基于体重的随机整群抽样方法,共纳入819名年龄在18 - 88岁的受试者。我们构建了一个逻辑回归模型,以确定代谢综合征各组分及其数量与慢性肾脏病关联的校正比值比(OR)和95%置信区间(CI)。
代谢综合征的患病率为25.9%(女性为30.9%,男性为18.8%)。16.6%的参与者患有慢性肾脏病(男性:14%,女性:19.4%)。最常见的组分是腹型肥胖(63.6%),其次是高密度脂蛋白胆固醇降低(36.7%)、甘油三酯水平升高(31.7%)、高血压(25.6%)和空腹血糖升高(21.9%)。中心性肥胖和高密度脂蛋白水平降低在女性中更为常见(P < 0.001)。代谢综合征的存在与慢性肾脏病相关,慢性肾脏病的OR值升高(OR:3.07,95% CI 2.09 - 4.50;P < 0.001)。随着危险因素数量从1增加到≥3,校正后的OR(95% CI)分别为1.189(0.554 - 2.555)、2.025(0.990 - 4.141)和4.769(2.413 - 9.424)。在多变量分析中,患有高血压和腹型肥胖的个体患慢性肾脏病的易感性OR值更高。
我们的研究表明,伊朗人群中慢性肾脏病与代谢综合征之间存在密切关联。还建议应更早地检测出具有代谢危险因素的个体;他们还应接受多学科干预,以阻止代谢综合征各组分的恶化以及慢性肾脏病的发展。